Risuteganib Protects against Hydroquinone-induced Injury in Human RPE Cells.
Yang P, Shao Z, Besley NA, Neal SE, Buehne KL, Park J, Karageozian H, Karageozian V, Ryde IT, Meyer JN, Jaffe GJ.
Yang P, et al. Among authors: buehne kl.
Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):35. doi: 10.1167/iovs.61.10.35.
Invest Ophthalmol Vis Sci. 2020.
PMID: 32818234
Free PMC article.